Pneumococcal Disease in Older Adults--An Overview.
نویسنده
چکیده
1Senior Consultant Infectious Diseases Apollo Hospital, Adjunct Professor of Infectious Diseases SRMC and MGR Medical University P disease is a group of illnesses caused by a gram positive bacterium Streptococcus p n e u m o n i a e ( a l s o k n o w n a s “Pneumococcus”).1 Although more than 90 different pneumococcal serotypes are known, only a few of them are responsible for a major burden of pneumococcal disease.2,3
منابع مشابه
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
CONTEXT A conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-valent conjugate vaccine affects pneumococcal carriage and transmission. Early after its introduction, incidence of invasive pneumococcal disease declined among older adults, a group at high risk for pneumococcal diseas...
متن کاملPneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines.
Use of the pneumococcal conjugate vaccines among children in the U.S. since 2000 has dramatically reduced pneumococcal disease burden among adults. Significant vaccine-preventable morbidity and mortality from pneumococcal infections still remains, especially among older adults. The U.S. Advisory Committee on Immunization Practices (ACIP) has recently recommended the routine use of both pneumoco...
متن کاملAdult immunization--a neglected issue in Southeast Asia.
Adult immunization is a neglected and underpublicised issue in Southeast Asia. Vaccine-preventable diseases cause unnecessary morbidity and mortality among adults in the region, while inadequate immunization results in unnecessary costs, including those associated with hospitalization, treatment, and loss of income. Childhood vaccination coverage is high for the EPI diseases of diphtheria, teta...
متن کاملBurden of pneumococcal disease in adults aged 65 years and older: an Australian perspective
BACKGROUND The burden of pneumococcal disease in adults aged 65 years and older in Australia is not well defined. This retrospective cross-sectional study calculated rates for pneumococcal pneumonia using data from the Australian Institute of Health and Welfare and from the Bettering Evaluation and Care of Health program. METHODS Invasive pneumococcal disease (IPD) incidence was calculated us...
متن کاملPneumococcal vaccination of elderly adults: new paradigms for protection.
Pneumococcal polysaccharide vaccine has been licensed for use in the United States for >30 years, and two-thirds of the elderly population in the United States have received this vaccine. Observational studies have demonstrated that pneumococcal polysaccharide vaccine reduces the risk of invasive pneumococcal disease in immunocompetent elderly individuals, but neither observational studies nor ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of the Association of Physicians of India
دوره 63 4 Suppl شماره
صفحات -
تاریخ انتشار 2015